BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
SIRT1
,
Apoptosis
,
Obesity
,
Pancreas
,
Laser capture microdissection
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Abi- 1
Summary
General Info
Curated Studies
Most Correlated Studies
Testes expression profiles from ABDG8 KO and WT mice and ezetimibe treated ABDG8 KO mice
Livers of Wild-Type and PPARalpha-Null Mice Exposed to Perfluorooctanoic Acid (PFOA)
Colorectal cancer and normal colon rectal tissue before and after radiochemotherapy
Macrophage cell line RAW 264.7 cells treated with beta-hematin or 4-hydroxy-2-nonenal
Gene expression pancreatic cancer cell lines: primary vs metastatic
Explore Curated Studies Results
Literature
Most Relevant Literature
ABI1-based expression signature predicts breast cancer metastasis and survival.
Abelson interactor 1 splice isoform-L plays an anti-oncogenic role in colorectal carcinoma through i…
RAF22, ABI1 and OST1 form a dynamic interactive network that optimizes plant growth and responses to…
TMK1-based auxin signaling regulates abscisic acid responses via phosphorylating ABI1/2 in Arabidops…
Acetylation of Abelson interactor 1 at K416 regulates actin cytoskeleton and smooth muscle contracti…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas
Trial of ABI-007 Plus S-1 as Second-line Chemotherapy in Advanced Gastric Cancer Patients
Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer
ABI for Screening of Coronary Artery Disease
A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjec…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ